Back
Brighthouse Financial Vs. Kymera Therapeutics Industry Stock Comparison
Buy
81
BHF
Brighthouse Financial
Last Price:
$52.11
Seasonality Move:
4.31%
Buy
53
KYMR
Kymera Therapeutics
Last Price:
$43.43
Seasonality Move:
5.78%
Buy
81
Brighthouse Financial (BHF)
is a Buy
Is Brighthouse Financial a Buy, Sell or Hold?
-
The current Brighthouse Financial [BHF] share price is $52.11. The Score for BHF is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
BHF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
53
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $43.43. The Score for KYMR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BHF Stock Price Chart
What is Brighthouse Financial's stock price today?
-
The Brighthouse Financial share price today is $52.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BHF is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
BHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.56 | Sell |
Relative Strength Index (14 RSI): | 36.76 | Sell |
Chaikin Money Flow: | 201112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.67 - 58.97) | Sell |
Bollinger Bands (100): | (53.04 - 60.22) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.46 | Buy |
Relative Strength Index (14 RSI): | 52.12 | Buy |
Chaikin Money Flow: | -176647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.14 - 47.42) | Sell |
Bollinger Bands (100): | (27.24 - 41.98) | Buy |
BHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.22 | Sell |
20-day SMA: | 55.72 | Sell |
50-day SMA: | 57.49 | Sell |
200-day SMA: | 52.97 | Sell |
8-day EMA: | 53.21 | Sell |
20-day EMA: | 55.04 | Sell |
50-day EMA: | 56.18 | Sell |
200-day EMA: | 53.71 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.31 | Sell |
20-day SMA: | 45.91 | Sell |
50-day SMA: | 38.46 | Buy |
200-day SMA: | 39.53 | Buy |
8-day EMA: | 9.65 | Buy |
20-day EMA: | 4.14 | Buy |
50-day EMA: | 1.7 | Buy |
200-day EMA: | 0.43 | Buy |
Brighthouse Financial Earnings Growth & BHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.46 per share, a decrease this year of $1.66 per share, and an increase next year of $2.81 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.
Brighthouse Financial Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |